Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 EPS of $0.19

February 13, 2013 4:18 PM

Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q4 EPS of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found